The hidden CDC trial data for Jynneos vaccine, aka Imvamune, Imvanex and MVA-BN

Broadcast Message

CDC conducted a Jynneos clinical trial on 1,000 Congolese healthcare workers (2017-2020) but allegedly concealed safety and efficacy data. The initial trial was reported as completed, but CDC later changed it to ongoing, seeking 600 additional subjects. NIH is now conducting a separate safety study using Congolese participants. The author intends to further investigate and inform the public about the situation regarding the vaccines.

Link
https://merylnass.substack.com/p/the-hidden-cdc-trial-data-for-jynneos

The hidden CDC trial data for Jynneos vaccine, aka Imvamune, Imvanex and MVA-BN Why did they keep changing the name? MVA stands for an old vaccine "Modified Vaccinia Ankara," used in 2003 for US soldiers at high risk of reactions to other smallpox vaccines. Wed, 14 Aug 2024 19:17:22 GMT https://merylnass.substack.com/p/the-hidden-cdc-trial-data-for-jynneos CDC performed a clinical trial of Jynneos (= MVA-BN)(= Imvamune) in 1000 Congolese healthcare workers from 2017-2020. However, CDC has covered up the safety and efficacy data from that trial. Below CDC bragged about the trial after it commenced. There should have been plenty of safety data with 1,000 subjects, down from the proposed 1600. Did the trial stop early due to safety issues?

There was a Clinicaltrials.gov posting that said the trial had ended in 2020. I linked to it in 2022.

But CDC bureaucrats know 6 ways from Sunday how to CYA. So CDC replaced that old Clinicaltrials.gov post (which said the trial was completed) with a new one, which claims this is an ongoing trial, and they are now seeking those additional 600 subjects that were not recruited in 2017-2020. Hmmm. They will give these new subjects a newer version of the vaccine, which is freeze-dried by Bavarian Nordic. And now they don’t need to explain why the 2017 trial has never reported its data. A win-win for CDC.

https://clinicaltrials.gov/study/NCT02977715

NIH decided to perform a similar study, again using Congolese as subjects, to assess the safety of the vaccine, this year . Using a different name of the vaccine. Just for safety, not efficacy. Phase 1. Hmmm.

I will do a deeper dive into all this, but I want this information to be available before people are told to roll up their sleeve for these highly questionable “vaccines.”